This session will focus on how LC-MS is being explored for use in clinical and translational science for diagnosis, therapy, and monitoring of male infertility and cancer. The use of LC-MS as a screening platform is rapidly enabling novel protein biomarkers for advancing the future of healthcare. Our methods using LC-MS bridge between the deep focus of proteomics and flexibility of clinical translational research to discover new and innovative biomarkers for male infertility and cancer. This session is meant for Scientists, Researchers, and Physicians who work at pharma/biotech companies, academic medical centers, and universities who are interested in a new approach to identify and further validate biomarkers for cancer.